The Impact of Breakthrough Therapy Designation on Development and Approval of Drugs and Biologics Intended for USE in Pediatric Cancer

被引：0
|
作者：
Casey, D. [1 ]
Barone, A. [1 ]
Marcus, L. [1 ]
Baird, K. [2 ]
Singh, S. [1 ]
Reaman, G. [1 ]
机构：
[1] US FDA, Off Oncol Dis, Silver Spring, MD USA
[2] US FDA, Off Tissues & Adv Therapies, Silver Spring, MD USA
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0489
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [1] Impact of breakthrough therapy designation on cancer drug development
    Michael Shea
    Linda Ostermann
    Ryan Hohman
    Samantha Roberts
    Marina Kozak
    Ryan Dull
    Jeff Allen
    Ellen Sigal
    Nature Reviews Drug Discovery, 2016, 15 : 152 - 152
  • [2] Impact of breakthrough therapy designation on cancer drug development
    Shea, Michael
    Ostermann, Linda
    Hohman, Ryan
    Roberts, Samantha
    Kozak, Marina
    Dull, Ryan
    Allen, Jeff
    Sigal, Ellen
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (03) : 152 - 152
  • [3] The Impact of Breakthrough Therapy Designation on Development Strategies and Timelines for Nononcology Drugs and Vaccines
    Poirier, A. F.
    Murphy, W. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 603 - 605
  • [4] Accelerated Approval and Breakthrough Therapy Designation: Oncology Drug Development on Speed?
    Yao, James C.
    Meric-Bernstam, Funda
    Lee, J. Jack
    Eckhardt, S. Gail
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4305 - 4308
  • [5] Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
    Puthumana, Jeremy
    Wallach, Joshua D.
    Ross, Joseph S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (03): : 301 - 303
  • [6] Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Granted Breakthrough Therapy Designation in China, 2020-2024
    Luo, Xingxian
    Du, Xin
    Lv, Xufeng
    Yang, Yue
    Zhang, Xiaohong
    Huang, Lin
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [7] Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
    Herink, Megan C.
    Johnston, Kirbee
    Breninger, Kristin
    Wu, Erin
    Irwin, Adriane N.
    PHARMACY, 2022, 10 (05)
  • [8] Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation
    Kesselheim, Aaron S.
    Woloshin, Steven
    Eddings, Wesley
    Franklin, Jessica M.
    Ross, Kathryn M.
    Schwartz, Lisa M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (14): : 1516 - 1518
  • [9] Breakthrough therapy designation for pancreatic cancer vaccine combo
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2779 - 2780
  • [10] Breakthrough therapy: FDA's new designation for accelerating approval of promising pipeline therapies
    Calabrese, David
    FORMULARY, 2013, 48 (08) : 275 - 276
12345